Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Oncology

Journal Scan / Research · June 13, 2023

CD38 as a Pan-Hematologic Target for CAR T Cells

Blood Advances

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Charles Gaulin MBBS

Blood Advances
CD38 as a pan-hematologic target for chimeric antigen receptor T cells
Blood Adv 2023 May 12;[EPub Ahead of Print], T Glisovic-Aplenc, C Diorio, JA Chukinas, K Veliz, O Shestova, F Shen, S Nunez-Cruz, TL Vincent, F Miao, MC Milone, CH June, DT Teachey, SK Tasian, R Aplenc, SI Gill

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated